Free Trial
NYSE:NSPR

InspireMD (NSPR) Stock Price, News & Analysis

InspireMD logo
$2.54 -0.16 (-5.76%)
As of 03:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About InspireMD Stock (NYSE:NSPR)

Key Stats

Today's Range
$2.50
$2.71
50-Day Range
$2.43
$3.70
52-Week Range
$1.81
$3.80
Volume
139,483 shs
Average Volume
56,725 shs
Market Capitalization
$75.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.75
Consensus Rating
Buy

Company Overview

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Remove Ads

InspireMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

NSPR MarketRank™: 

InspireMD scored higher than 49% of companies evaluated by MarketBeat, and ranked 588th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InspireMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    InspireMD has received no research coverage in the past 90 days.

  • Read more about InspireMD's stock forecast and price target.
  • Earnings Growth

    Earnings for InspireMD are expected to grow in the coming year, from ($0.79) to ($0.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InspireMD is -3.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InspireMD is -3.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InspireMD has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NSPR.
  • Dividend Yield

    InspireMD does not currently pay a dividend.

  • Dividend Growth

    InspireMD does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NSPR.
  • News Sentiment

    InspireMD has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for InspireMD this week, compared to 1 article on an average week.
  • MarketBeat Follows

    1 people have added InspireMD to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InspireMD insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    29.72% of the stock of InspireMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    44.78% of the stock of InspireMD is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InspireMD's insider trading history.
Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

NSPR Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
InspireMD reports Q4 EPS (19c) vs (16c) last year
See More Headlines

NSPR Stock Analysis - Frequently Asked Questions

InspireMD's stock was trading at $2.63 on January 1st, 2025. Since then, NSPR stock has decreased by 3.6% and is now trading at $2.5350.
View the best growth stocks for 2025 here
.

InspireMD, Inc. (NYSE:NSPR) released its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.04. The firm had revenue of $1.81 million for the quarter, compared to analyst estimates of $1.74 million. InspireMD had a negative net margin of 413.96% and a negative trailing twelve-month return on equity of 69.42%.

Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InspireMD investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL), Adobe (ADBE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/12/2024
Today
4/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:NSPR
Fax
N/A
Employees
50
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.75
High Stock Price Target
$5.00
Low Stock Price Target
$4.50
Potential Upside/Downside
+76.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-19,920,000.00
Net Margins
-413.96%
Pretax Margin
-413.00%

Debt

Sales & Book Value

Annual Sales
$7.01 million
Price / Cash Flow
N/A
Book Value
$1.83 per share
Price / Book
1.47

Miscellaneous

Free Float
18,332,000
Market Cap
$79.87 million
Optionable
Optionable
Beta
0.88
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NYSE:NSPR) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners